Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Angiogenesis in endocrine tumors.

Helen E Turner1, Adrian L Harris, Shlomo Melmed

  • 1Department of Endocrinology, Churchill Hospital, Oxford OX3 7LJ, United Kingdom.

Endocrine Reviews
|October 23, 2003
PubMed
Summary

Angiogenesis, the formation of new blood vessels, is crucial for tumor growth and spread. Understanding angiogenesis in endocrine tumors can guide targeted treatments for aggressive disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Generating exosome subtypes: diverse membrane origins and mergers.

Trends in cell biology·2026
Same author

SET1B Drives Sustained HIF activity and Disease Progression in Clear Cell Renal Cell Carcinoma.

Cancer research·2026
Same author

Immune Checkpoint Inhibitor Therapy Induced Hypophysitis; A Tertiary Care Centre Experience; Highlighting Detection, Treatment Outcomes and Long Term Endocrinopathies and Recovery.

Clinical endocrinology·2026
Same author

Editorial Expression of Concern: Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.

Nature medicine·2026
Same author

Approach to the Patient With Turner Syndrome.

The Journal of clinical endocrinology and metabolism·2025
Same author

A systems-based approach to uterine fibroids identifies differential splicing associated with abnormal uterine bleeding.

Communications medicine·2025

Area of Science:

  • Endocrinology
  • Oncology
  • Vascular Biology

Background:

  • Angiogenesis, the development of new blood vessels, is vital for tumor growth, progression, and metastasis.
  • Endocrine glands rely on a robust blood supply for normal function and hormone regulation.
  • Factors influencing angiogenesis include growth factors (like VEGF), inhibitors, extracellular matrix interactions, hypoxia, and hormonal changes (estrogen, IGF-I, TSH).

Purpose of the Study:

  • To explore the role and significance of angiogenesis in various endocrine tumors.
  • To investigate the relationship between angiogenesis, microvascular density, and tumor behavior (aggressiveness, invasiveness).
  • To identify potential therapeutic targets by understanding vascular control mechanisms in endocrine neoplasms.

Main Methods:

  • Measurement of microvascular density in endocrine tumors.
  • Analysis of angiogenic factors, such as vascular endothelial growth factor (VEGF).
  • Comparison of vascularity between normal endocrine tissue and tumors, including benign and malignant types.

Main Results:

  • Pituitary tumors exhibit lower vascularity than normal pituitary tissue, with variable correlations to tumor aggressiveness.
  • Adrenal tumors, particularly those in Von Hippel Lindau disease, show characterized vascular mechanisms with ongoing antiangiogenic therapy trials.
  • Thyroid tumors are more vascular than normal thyroid tissue, with increased VEGF expression linked to aggressive behavior and metastasis.

Conclusions:

  • Angiogenesis plays a differential role in various endocrine tumors, impacting their behavior and prognosis.
  • Understanding angiogenesis and vascular control in endocrine tumors is essential for developing targeted therapies.
  • Further research into angiogenic factors and microvascular density in parathyroid and other endocrine tumors is warranted for improved clinical decision-making.

Related Experiment Videos